Format

Send to

Choose Destination
J Natl Compr Canc Netw. 2016 May;14(5):509-19.

NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.

Author information

1
UCSF Helen Diller Family Comprehensive Cancer Center
2
UC San Diego Moores Cancer Center
3
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
4
The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute
5
Mayo Clinic Cancer Center
6
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
7
Massachusetts General Hospital Cancer Center
8
The University of Texas MD Anderson Cancer Center
9
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
10
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
11
Prostate Health Education Network
12
Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center
13
City of Hope Comprehensive Cancer Center
14
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
15
University of Washington Medical Center/Seattle Cancer Care Alliance
16
Dana-Farber/Brigham and Women’s Cancer Center
17
Huntsman Cancer Institute at the University of Utah
18
University of Colorado Cancer Center
19
Roswell Park Cancer Institute
20
University of Michigan Comprehensive Cancer Center
21
Vanderbilt-Ingram Cancer Center
22
Moffitt Cancer Center
23
Duke Cancer Institute
24
University of Alabama at Birmingham Comprehensive Cancer Center
25
Fox Chase Cancer Center
26
Stanford Cancer Center
27
Yale Cancer Center/Smilow Cancer Hospital
28
Memorial Sloan Kettering Cancer Center
29
St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center
30
National Comprehensive Cancer Network

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.

PMID:
27160230
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center